Gold prices bounce off 3-week lows; demand likely longer term
Investing.com -- Shares of DKSH fell 6.5% following the release of their annual core operating profit, which met market expectations but failed to enthuse investors.
The company, which specializes in expansion services, particularly in the healthcare sector, revealed core earnings before interest and taxes (EBIT) of 343.1 million Swiss francs ($365.76 million) for the year 2024, closely aligning with the analysts’ forecast of 344.3 million francs from a Vara Research poll.
Despite the steady performance, the Zurich-based firm’s stock experienced a downturn. The company’s forecast for 2025 indicates an expectation of higher core earnings than the previous year, although no specific figures were provided.
DKSH emphasized its optimism regarding the Asia Pacific region’s long-term potential and its strategic positioning to capitalize on favorable market trends, industry dynamics, and merger and acquisition opportunities.
The company generates approximately 70% of its sales in South East Asia, a region that is becoming increasingly significant as some companies relocate production from China to mitigate risks from geopolitical tensions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.